Gefitinib

英文名： Gefitinib

别名： 吉非替尼;N-(3-氯-4-氟苯基)-7-甲氧基-6-(3-吗啉-4-丙氧基)喹唑啉-4-胺;吉非替尼(易瑞沙);4-氨基-1Boc-哌啶-4-羧酸;Gefitinib 抑制剂;吉非替尼标准品;吉非替尼Gefitinib;吉非替尼Iressa;吉非替尼靶向药;吉非替尼粉末;吉非替尼固体状;吉非替尼杂质;吉非替尼杂质对照品;吉非替尼中间体;科研实验吉非替尼;临床实验吉非替尼;盐酸吉非替尼;盐酸伊达比星;医药级吉非替尼;4-喹唑啉胺,N-(3-氯-4-氟苯基)-7-甲氧基-6-[3-(4-吗啉基)丙氧基];吉非替尼吉菲替尼;易瑞沙;N-(3-氯-4-氟苯基)-7-甲氧基-6-(3-吗啉基丙氧基)喹唑啉-4-胺;格非替尼;吉非替尼API;GEFI锡IB;吉非替尼(标准品);吉非替尼工作对照品;吉非替尼(替尼类);易瑞沙(吉非替尼);吉非替尼(对照品) 展开

产品编号： A2322636

CAS No.： 184475-35-2

分子式： C₂₂H₂₄ClFN₄O₃

分子量： 446.90

收藏产品大包装咨询？

货号	规格	纯度	目录价	您的价格	华东	华中	华北	华南	西南	数量	购物车
A2322636-10mg	10mg		¥9719.90		0	0	0	0	0
A2322636-50mg	50mg		¥29159.90		0	0	0	0	0

中文名称	Gefitinib
中文别名	吉非替尼;N-(3-氯-4-氟苯基)-7-甲氧基-6-(3-吗啉-4-丙氧基)喹唑啉-4-胺;吉非替尼(易瑞沙);4-氨基-1Boc-哌啶-4-羧酸;Gefitinib 抑制剂;吉非替尼标准品;吉非替尼Gefitinib;吉非替尼Iressa;吉非替尼靶向药;吉非替尼粉末;吉非替尼固体状;吉非替尼杂质;吉非替尼杂质对照品;吉非替尼中间体;科研实验吉非替尼;临床实验吉非替尼;盐酸吉非替尼;盐酸伊达比星;医药级吉非替尼;4-喹唑啉胺,N-(3-氯-4-氟苯基)-7-甲氧基-6-[3-(4-吗啉基)丙氧基];吉非替尼吉菲替尼;易瑞沙;N-(3-氯-4-氟苯基)-7-甲氧基-6-(3-吗啉基丙氧基)喹唑啉-4-胺;格非替尼;吉非替尼API;GEFI锡IB;吉非替尼(标准品);吉非替尼工作对照品;吉非替尼(替尼类);易瑞沙(吉非替尼);吉非替尼(对照品)
英文名称	Gefitinib
英文别名	N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine;GEFITINIB;AKOS 91371;n-(3-chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine;N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-4-quinazolinamine;ZD 1839;4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-;Gefitinib(TINIBS);Gefitinib (ZD1839);Gefitinib (ZD1839, Iressa®);Iressa;N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine; Irressat;ZD-1839;Gefinitib;Getfitnib;Gifitinib;Ji Fei Ji;Gefitinib WS;ZD1839;Gefitinib, >=99%;Gefitinib iMpurity;N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4-amine;4-(3'-Chloro-4'-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline;N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholiny;N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4;DTXSID8041034;C22H24ClFN4O3;KS-1204;D01977;Kinome_3322;(3-CHLORO-4-FLUORO-PHENYL)-[7-METHOXY-6-(3-MORPHOLIN-4-YL-PROPOXY)-QUINAZOLIN-4-YL]-AMINE;184475-35-2;Gefitinib,ZD-1839,Iressa;Q417824;SR-00000000262-2;BG164498;Iressa (AstraZeneca);AB01273954-01;BRD-K64052750-001-23-3;Z1546610485;gefitinibum;HMS3714A05;Kinome_3321;HMS3295A21;Gefitinib (JP18/USAN/INN);DTXCID6021034;SW199108-4;GEFITINIB [EP MONOGRAPH];HY-50895;HMS3748E17;HMS3413H08;SR-00000000262;NCGC00159455-03;CS-0124;GEFITINIB (MART.);BCP01365;HMS3677H08;NCGC00159455-02;N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamine;CHEMBL939;NCGC00159455-06;UNII-S65743JHBS;NSC715055;NSC-715055;3-Chloro-4-Fluoro-N-[(4z)-7-Methoxy-6-(3-Morpholin-4-Ylpropoxy)quinazolin-4(1h)-Ylidene]aniline;Q-201149;NSC 759856;HY-50895G;Tox21_111683_1;CAS-184475-35-2;CHEBI:49668;NSC759856;GEFITINIB [INN];G-4408;HMS3244M21;SY002154;4-[(3-Chloro-4-fluorophenyl)amino]-7-methoxy-6-(3-morpholinopropoxy)quinazoline;NSC-800105;SDCCGSBI-0634411.P005;NCGC00159455-09;Iressa (TN);CS-0622782;GEFITINIB [WHO-DD];SR-00000000262-3;s1025;Gefitinib, >=98% (HPLC);AB01273954-02;BCP9000718;GTPL4941;CU-00000000396-1;STK621310;Gefitinib (ZD1839)?;SMR002204119;4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-4-morpholin)propoxy)-;HMS3654A07;NS00006312;6-(3-morpholinopropoxy)-N-(3-chloro-4-fluorophenyl)-7-methoxyquinazolin-4-amine;NCGC00159455-14;BRD-K64052750-001-22-5;BCPP000221;DB00317;MLS003899193;BRD-K64052750-001-17-5;NCGC00159455-08;K00240;HMS3244N21;Gefitinib (GMP);AC-1556;SCHEMBL7866;cid_123631;NCGC00159455-04;NSC-759856;G0546;Gefitini; Iressa;IRE;S65743JHBS;BRD-K64052750-001-16-7;GEFITINIB [MI];L01XE02;EN300-123024;HMS3244M22;GEFITINIB [EMA EPAR];GEFITINIB [VANDF];GEFITINIB [ORANGE BOOK];GEFITINIB [MART.];CCG-220642;N-(3-chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine;Gefitinib [USAN:INN:BAN];AKOS000280752;Gefitinib, EuropePha...
CAS号	184475-35-2
分子式	C₂₂H₂₄ClFN₄O₃
分子量	446.90

象形图
警示语
Class
警告声明
UNub
危险声明
Packing Group

暂无相关资料！

搜索质检报告(COA)

搜索MSDS

相关产品

订购指南

支付方式

配送说明

售后服务

关于我们

微信公众号